BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld
BioWorld
March 29, 2010
View Archived Issues
Cardio-Renal Player CorMedix Raises $12.5M in AMEX Debut
CorMedix Inc. caught much of the biotech industry by surprise late Thursday when the relatively obscure cardio-renal specialty pharma firm priced a $12.5 million initial public offering on AMEX. (BioWorld Today)
Read More
Biovail Expands CNS Pipeline, Paying $10M for Cortex Drugs
Read More
Much-Needed Financing Adds $49.5M for Somaxon's Silenor
Read More
GAO: FDA Management Faults Carries Risks for Consumers
Read More
Clinic Roundup
Read More
Vital Signs
Read More
Other News To Note
Read More
Stock Movers
Read More
Appointments And Advancements
Read More
Bench Press
Read More